Skip to content

Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03816202
Enrollment
100
Registered
2019-01-25
Start date
2019-04-25
Completion date
2019-08-27
Last updated
2022-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Stenosis

Brief summary

The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.

Interventions

DEVICESundt carotid shunt

The Integra Sundt™ carotid shunts are indicated for temporary carotid artery bypass during carotid endarterectomy procedures to help protect the cerebral hemispheres from ischemia during the period of carotid artery occlusion.

Sponsors

Integra LifeSciences Corporation
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 18-80 years old * Have undergone carotid endarterectomy with any Integra Sundt™ carotid shunt on or before date of study initiation * Availability of records on post-operative imaging of the carotid artery either by carotid duplex ultrasound or angiogram

Exclusion criteria

* Insertion of a carotid shunt at the site of an infection

Design outcomes

Primary

MeasureTime frameDescription
Evidence of Injury to the Artery or Cerebral Ischemia Secondary to Shunt Placement and Removalup to 60 days post-procedureNumber of participants with injury to the artery or cerebral ischemia secondary to shunt placement and removal

Countries

United States

Participant flow

Participants by arm

ArmCount
Sundt Carotid Shunt
Subject has undergone a endarterectomy procedure with the use of the Sundt Carotid Shunt.
100
Total100

Baseline characteristics

CharacteristicSundt Carotid Shunt
Age, Continuous68.5 years
STANDARD_DEVIATION 6.8
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
37 Participants
Sex: Female, Male
Male
63 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 100
other
Total, other adverse events
3 / 100
serious
Total, serious adverse events
0 / 100

Outcome results

Primary

Evidence of Injury to the Artery or Cerebral Ischemia Secondary to Shunt Placement and Removal

Number of participants with injury to the artery or cerebral ischemia secondary to shunt placement and removal

Time frame: up to 60 days post-procedure

Population: number of cases where there is evidence of injury to the artery or cerebral ischemia injury secondary to shunt placement and removal

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sundt Carotid ShuntEvidence of Injury to the Artery or Cerebral Ischemia Secondary to Shunt Placement and Removal3 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026